Cazzola M - Search Results

1

A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis.

Passamonti F, Giorgino T, Mora B, Guglielmelli P, Rumi E, Maffioli M, Rambaldi A, Caramella M, Komrokji R, Gotlib J, Kiladjian JJ, Cervantes F, Devos T, Palandri F, De Stefano V, Ruggeri M, Silver RT, Benevolo G, Albano F, Caramazza D, Merli M, Pietra D, Casalone R, Rotunno G, Barbui T, Cazzola M, Vannucchi AM. Passamonti F, et al. Among authors: cazzola m. Leukemia. 2017 Dec;31(12):2726-2731. doi: 10.1038/leu.2017.169. Epub 2017 May 31. Leukemia. 2017. PMID: 28561069

2

Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis.

Passamonti F, Malabarba L, Orlandi E, Pascutto C, Brusamolino E, Astori C, Baratè C, Canevari A, Corso A, Bernasconi P, Cazzola M, Lazzarino M. Passamonti F, et al. Among authors: cazzola m. Br J Haematol. 2002 Mar;116(4):855-61. doi: 10.1046/j.0007-1048.2002.03367.x. Br J Haematol. 2002. PMID: 11886392 Free article.

3

Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders.

Passamonti F, Vanelli L, Malabarba L, Rumi E, Pungolino E, Malcovati L, Pascutto C, Morra E, Lazzarino M, Cazzola M. Passamonti F, et al. Among authors: cazzola m. Haematologica. 2003 Oct;88(10):1123-9. Haematologica. 2003. PMID: 14555308

4

Long-term follow-up of young patients with essential thrombocythemia treated with pipobroman.

Passamonti F, Rumi E, Malabarba L, Arcaini L, Orlandi E, Brusamolino E, Pascutto C, Cazzola M, Lazzarino M. Passamonti F, et al. Among authors: cazzola m. Ann Hematol. 2004 Aug;83(8):495-7. doi: 10.1007/s00277-004-0882-7. Epub 2004 Jun 3. Ann Hematol. 2004. PMID: 15175894 No abstract available.

5

Clinical significance of neutrophil CD177 mRNA expression in Ph-negative chronic myeloproliferative disorders.

Passamonti F, Pietra D, Malabarba L, Rumi E, Della Porta MG, Malcovati L, Bonfichi M, Pascutto C, Lazzarino M, Cazzola M. Passamonti F, et al. Among authors: cazzola m. Br J Haematol. 2004 Sep;126(5):650-6. doi: 10.1111/j.1365-2141.2004.05098.x. Br J Haematol. 2004. PMID: 15327515 Free article.

6

Cytoreductive therapy for patients with essential thrombocythemia at high risk of thromboembolic complications. The difficult choice of the optimal drug.

Passamonti F, Cazzola M. Passamonti F, et al. Among authors: cazzola m. Haematologica. 2004 Nov;89(11):1284. Haematologica. 2004. PMID: 15531447 No abstract available.

7

Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia.

Passamonti F, Rumi E, Pungolino E, Malabarba L, Bertazzoni P, Valentini M, Orlandi E, Arcaini L, Brusamolino E, Pascutto C, Cazzola M, Morra E, Lazzarino M. Passamonti F, et al. Among authors: cazzola m. Am J Med. 2004 Nov 15;117(10):755-61. doi: 10.1016/j.amjmed.2004.06.032. Am J Med. 2004. PMID: 15541325

8

PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia.

Passamonti F, Pietra D, Rumi E, Arcaini L, Della Porta MG, Malcovati L, Pascutto C, Lazzarino M, Cazzola M. Passamonti F, et al. Among authors: cazzola m. Leukemia. 2005 May;19(5):888-9. doi: 10.1038/sj.leu.2403700. Leukemia. 2005. PMID: 15744342 No abstract available.

9

Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome.

Malcovati L, Della Porta MG, Lunghi M, Pascutto C, Vanelli L, Travaglino E, Maffioli M, Bernasconi P, Lazzarino M, Invernizzi R, Cazzola M. Malcovati L, et al. Among authors: cazzola m. Leukemia. 2005 May;19(5):776-83. doi: 10.1038/sj.leu.2403680. Leukemia. 2005. PMID: 15789068 Clinical Trial.

10

A gain-of-function mutation of JAK2 in myeloproliferative disorders.

Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC. Kralovics R, et al. Among authors: cazzola m. N Engl J Med. 2005 Apr 28;352(17):1779-90. doi: 10.1056/NEJMoa051113. N Engl J Med. 2005. PMID: 15858187 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,226 results

Search Page